Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
manufacturing issues
Manufacturing
FDA rejects Eylea HD for ongoing manufacturing issues
After an FDA rejection for high-dose Eylea, Regeneron said that it is making progress in its efforts to secure alternate manufacturing help.
Kevin Dunleavy
Oct 28, 2025 11:52am
Novo plant issues may mean delays for Regeneron, Scholar Rock
Oct 13, 2025 3:48pm
FDA slams Ali Pharma with warning over porcine API production
Nov 1, 2023 9:05am
FDA flags 'deficient' manufacturing standards at Global Pharma
Apr 4, 2023 8:35am
AstraZeneca still plans to seek U.S. approval of its COVID shot
Apr 21, 2021 2:20pm
B. Braun commits $1B to expand in face of IV fluid shortages
May 15, 2019 9:50am
